WELCOME MESSAGE

Conference Series invites all the experts and researchers from the Neuroscience and Dementia sector all over the world to attend 16th International Conference on Neuroscience and Dementia which is going to be held on December 21-22, 2022 at London, United Kingdom. Neuro Disorder 2022 includes Keynote presentations, Oral talks, Poster Presentations, Workshops, and Exhibitors.

ABOUT CONFERENCE

Neuroscience is the study of the nervous system's functions, including those of the brain, spinal cord, and peripheral nervous system. To comprehend the basic and emergent characteristics of neurons, glia, and neural circuits, it is a multidisciplinary science that combines physiology, anatomy, molecular biology, developmental biology, cytology, psychology, physics, computer science, chemistry, medicine, statistics, and mathematical modeling. The field of neuroscience now encompasses a variety of methods for studying the neurological system at various scales. Neuroscientists now employ a wide range of methods, from cellular and molecular analyses of individual neurons to imaging of sensory, motor, and cognitive functions in the brain.

The Latin word demens, which meaning to be insane, is the source of the word dementia. Dementia is a condition that typically appears when the brain is harmed by disease or injury and presents as a group of connected symptoms. Progressive memory, cognitive, and behavioral deficits are among the symptoms, which have a detrimental effect on a person's capacity to operate and do daily tasks. Despite the fact that dementia primarily affects older persons, it is not a natural aspect of ageing. Some dementia patients have emotional instability and personality changes. It primarily affects adults over 65. As people get older, their chances of having dementia greatly increase. One in 14

The Best Post Awards, Best Oral Presentation Awards, Young Researchers Forums (YRF), and Expert Video Presentation are all included in the Neuro Disorder 2022 Conference. We are pleased to invite you to attend and sign up for the "International Conference on Neuroscience and Dementia" which will be held December 21-22, 2022 at London, United Kingdom.

WHY TO ATTEND..?

The Conference will truly reflect the current trends, new strategies, recent advances, new approaches and future trends in Neuroscience and Dementia. We hope and intend that this online gathering, which will bring together neurologists, psychiatrists, mental health specialists, caregivers, nurses, and practitioners from around the world to discuss difficulties and improved approaches to dementia care, will not be an exception. Join this conference to increase your knowledge and share your views with the researchers and students who will be in attendance from different parts of the world. Join this seminar to increase your knowledge and share your valuable words.

·        Thus, our motive is, to generate platforms which will gather eminent scientists who will undoubtedly enrich our meeting during the Q&A sections.

·        Best stage to flourish new association and coordinated efforts.

·        Best area to accelerate your course into each domain in the World.

·        89% our meeting participants are the Key contact in their labs buying choices.

·        Our exhibitor corners were visited 4-5 times by 80% of the participants during the gathering.

·        Past exhibitor's input uncovers abundant of enquiries saw from the meeting participants.

·        Organization advancement with both Academia and Business.

Be the first to showcase your research, innovation and brand to gain competitive advantages. Meet your target audience and explore your product and services.

·        To Meet Experts

·        Learning In a New Space

·        New Tips & Tactics

·        Certification

·        Global Networking

·        Rebuild New Customer Base

Target Audience:

• Neurologists
• Psychiatry and Mental Health Professionals
• Primary care providers including Physicians, Nurses and Social Workers
• Diagnostic Laboratories
• Dementia Related Societies and Associations
• Neurophysiologists and Neuropsychologists
• Dementia Care Givers
• Academicians including Professors
• PhD Scholars
• Students carrying out laboratory and field studies
• Training Institutes
• Business Entrepreneurs
• Biological Psychologist
• Dementia Professionals
• Dementia Caregivers
• Dementia patients
• Neuroscientist
• Neurobiologist
• Neurosurgeons
• Rehabilitation physicians
• Brain Researchers
• Brain injury survivors

SESSIONS AND TRACKS

TRACK:1  Alzheimer’s Diseases

Alzheimer's disease is a brain ailment that gradually impairs thinking and memory abilities as well as the capacity to do even the most basic tasks. Symptoms of the late-onset kind often begin to show in the majority of patients in their mid-60s. Rarely, early-onset Alzheimer's strikes between the ages of 30 and 60. For older persons, Alzheimer's disease is the most typical cause of dementia.

TRACK:2  Vascular Dementia

A prevalent kind of dementia called vascular dementia is brought on by inadequate blood supply to the brain. In the UK, it is predicted to have an impact on about 150,000 individuals. The term "dementia" refers to issues with cognition brought on by slow-moving alterations and brain damage. In those under 65, it is uncommon.

TRACK:3  Therapeutic Approach towards Dementia

Treatment for dementia frequently entails a mix of dietary adjustments, pharmaceuticals, treatments, and methods for controlling behaviour and symptoms. Treatment for dementia-related behaviours, such as mood swings, sleep issues, and violence, may use a variety of techniques. The National Institute for Health and Care Excellence (NICE) presently only explicitly recommends cognitive stimulation therapy as a psychological dementia treatment for those with mild to moderate dementia.

TRACK:4  Ageing & Dementia

 Aging does not necessarily cause dementia. It comprises the decline in behavioural skills and cognitive capacities, such as thinking, remembering, learning, and reasoning, to the point that it affects a person's quality of life and daily activities.

TRACK:5  Neuroimaging Biomarker

Brain imaging methods are used by neuroimaging biomarkers to scan the morphology, function, microenvironment, metabolism, and molecular makeup of the brain and its lesions. Examples of these techniques are MRI, fMRI, perfusion MRI, and PET-FDG (Boland. 2014).

Assessment of beta-amyloid deposition with amyloid PET, measurement of brain metabolism with FDG-PET, and measurement of brain and hippocampal shrinkage with MRI are all examples of neuroimaging biomarkers for Alzheimer's disease (Bateman et al. 2012). Learn more about biomarkers for Alzheimer's disease identified through neuroimaging.

TRACK:6  Amyloid protein in Dementia

Amyloid protein buildup on the walls of the brain's arteries causes a disorder known as cerebral amyloid angiopathy (CAA). CAA raises the risk of stroke brought on by dementia and bleeding. The APP gene variants, also known as mutations, are the most frequent cause of hereditary cerebral amyloid angiopathy. The Dutch, Italian, Arctic, Iowa, Flemish, and Piedmont subtypes of this syndrome are caused by APP gene variations.

TRACK:7  Neurodegenerative Diseases

Neurodegenerative diseases are severe, incurable disorders that cause nerve cells to gradually deteriorate and/or die. This results in mobility issues (known as ataxias), cognitive issues (known as dementias), and affects a person's ability to move, speak, and breathe.

TRACK:8  Molecular Genetics and Biology of Dementia Neurology

The most typical cause of dementia is Alzheimer's disease (AD). The understanding of the genesis of AD has made significant strides in the last ten years, according to reports. A mutation in at least three separate genes can be the cause of familial early onset AD, which is a heterogeneous illness. Finding genetic risk factors for AD with a late start is the focus of current research. The authors will discuss the mapping research to find additional genes implicated in late-onset AD as well as the progress in understanding the pathogenic consequences of the genes altered in familial early onset AD in this paper.

TRACK:9  Neuro Radiology

 A branch of radiology known as neuroradiology uses neuroimaging methods to identify and classify abnormalities of the spine, head and neck, and central and peripheral nervous systems. Arteriovenous malformations, tumours, aneurysms, and strokes are among the medical conditions that neuroradiology may diagnose.

TRACK:10  Parkinson’s Diseases

Parkinson's disease is a chronic condition that affects both the neurological system and the bodily components that are under the control of the nervous system. Symptoms emerge gradually. The initial sign might be a little tremor in only one hand. Although tremors are typical, the disease might also make you stiff or move more slowly.

TRACK:11  Neuropsychology

 To encourage systematic exploration into brain-behavior links and to enhance therapeutic practise, neuropsychology places equal emphasis on basic research and applied, clinical research. The goal of neuropsychology is to disseminate the world's top ideas and research in the area.

TRACK:12  Neuro rehabilitation

 A medically supervised programme called neurological rehabilitation (rehab) is created for persons who have illnesses, injuries, or problems of the nervous system. Neurological rehabilitation frequently helps patients work better, experience fewer symptoms, and feel better overall.

TRACK:13  Pediatric Neurology

A paediatric neurologist, often known as a child neurologist, is a medical professional who deals with nervous system disorders in children. The brain, spine, nerves, or muscles might act as the starting point for nervous system issues. These may cause issues including migraines, seizures, or developmental delays. Autism, Attention Deficit Hyperactivity Disorder (ADHD), Dyspraxia, Epilepsy, Headaches, Dyslexia, Cerebral Palsy, and specialist neurologists are the neurological conditions that affect children most frequently.

TRACK:14  Neuro-ophthalmology

The field of medicine called neuro-ophthalmology is concerned with the visual symptoms brought on by illnesses of the brain. Eye movement issues or vision loss are two categories of visual complaints. Loss of vision may be caused by issues with the optic nerve or its connections to the brain's visual regions.

TRACK:15  Neurological Disorders

Numerous conditions fall under the category of neurological disability, including epilepsy, learning difficulties, neuromuscular diseases, autism, attention deficit disorder (ADD), brain tumours, and cerebral palsy, to mention a few. Congenital neurological problems are those that develop before to birth.

TRACK:16  Neuropharmacology

Neuropharmacology is the study of how medications affect the nervous system with the goal of creating treatments that can help people with neurological and mental disorders.

TRACK:17  Neurogenetics

Neurogenetics is the study of how heredity affects how the nervous system develops and works. It is based mostly on the observation that individuals' neurological systems, even those of the same species, may not be identical, and views neural features as phenotypes (i.e., manifestations, quantifiable or not, of an individual's genetic make-up). As its name suggests, it incorporates elements from both genetics and neurology research, concentrating on how an organism's genetic makeup influences the qualities that are manifested in that creature. Variations in this DNA sequence can affect a person's quality of life in a variety of ways.

TRACK:18  Neural Engineering

Within the field of biomedical engineering, neural engineering employs engineering methods to comprehend, restore, replace, or improve brain systems. To handle design issues at the intersection of live brain tissue and non-living constructions, neural engineers are particularly suited.

TRACK:19  Neuroimaging

Neuroimaging is the use of quantitative (computational) tools to investigate the composition and operation of the central nervous system. It was created as an impartial, non-invasive method of doing scientific research on a healthy human brain. It is increasingly being utilised for quantitative research on psychiatric and neurological disorders. Neuroimaging is not a medical speciality but rather a very interdisciplinary area of research.

TRACK:20  NeuroImmunology

Neuroimmunology is a branch of immunology that combines the study of the immune system with neuroscience, the study of the neurological system. Understanding the interconnections between these two intricate systems throughout development, homeostasis, and injury response is a goal of neuroimmunologists. Our understanding of the pathophysiology of several neurological illnesses, some of which have no obvious cause, will be further developed as a long-term aim of this rapidly evolving scientific field. Thus, neuroimmunology aids in the creation of novel pharmaceutical therapies for a number of neurological disorders.

TRACK:21  Neurosurgery

The medical speciality of neurosurgery, sometimes known as neurological surgery or brain surgery, focuses on the surgical management of illnesses affecting any part of the nervous system, including the brain, spinal cord, and peripheral nervous system.

TRACK:22  Neuropsychiatry

A field of medicine known as neuropsychiatry, often known as organic psychiatry, examines the relationship between psychiatry and neurology in an effort to comprehend and assign behaviour to the combination of neurobiology and social psychological elements.  While other behavioural and neurological specialities may view the mind and the brain as different entities, neuropsychiatry views the mind as "an emergent characteristic of the brain" The modern professions of psychiatry and neurology, which traditionally shared training, were preceded by neuropsychiatry; however, both disciplines have since split and are generally practised independently.

TRACK:23  Neuro-Oncology

The medical specialty of neurooncology deals with brain and spinal cord malignancies. Nervous system cancers are frequently serious illnesses that can ultimately be fatal.

TRACK:24  Computational Neurology

The field of neuroscience known as computational neuroscience, also referred to as theoretical neuroscience or mathematical neuroscience, uses computer simulations, theoretical analysis, and brain abstractions to better understand the principles governing the growth, structure, physiology, and cognitive abilities of the nervous system.

TRACK:25  Neuroplasticity

The capability of neuronal networks in the brain to alter via development and rearrangement is known as neuroplasticity, sometimes known as neural plasticity or brain plasticity. It occurs when the brain gets rewired to function differently from how it did previously.

MARKET ANALYSIS

A wide range of mental illnesses known as dementia slowly erode a person's ability to think and remember things. Despite advances in science and medicine, dementia's origins remain a mystery. As a result, the illness is only treated symptomatically.

The Dementia therapy is supportive and aims to minimise the intensity of the symptoms, however it is known that in many cases, movement disorders like Parkinson's are a trigger for dementia. The market for dementia therapies will grow from 2022 to 2029 at a CAGR of 8.50%, per Data Bridge Market Research's study.

Dynamics of the Dementia Treatment Market

Opportunities

Organizations both public and commercial are increasing their R&D spending. Over the course of the forecasting period, it is predicted that the dementia associated with Alzheimer's disease market would expand due to increasing R&D efforts in disease-modifying drugs and higher spending by key players in clinical trials of cutting-edge treatment options.

Restraints/Challenges

But it's expected that strict government regulations governing product clearance and the expensive costs associated with R&D activities would stifle industry development.

The latest developments, trade laws, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market participants, assessments of opportunities in terms of developing revenue pockets, changes in market laws, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, and geographic information are all included in this dementia treatment market research. To find out more about the market for dementia therapies, get in touch with Data Bridge Market Research. You may choose how to expand your market with the help of our professionals.

Patient Epidemiology - Analysis

According to Alzheimer's Disease International, there will be more than 50 million individuals living with dementia globally by 2022. This number is predicted to more than double every 20 years, reaching 82 million in 2030 and 152 million in 2050. The investigation began in June 2020 and is anticipated to be finished in December 2023.

You may also get a comprehensive market analysis of patient analysis, prognosis, and therapies in the dementia treatment market. The report contains data factors related to prevalence, incidence, mortality, and adherence rates. Direct or indirect influence evaluations of epidemiology on market growth are investigated in order to produce a more trustworthy and accurate multivariate statistical model for predicting the market over the growth phase.

The Impact of Covid-19 on the Dementia Treatment Market

The COVID-19 pandemic outbreak is expected to have a considerable influence on the market for dementia drugs. Due to their cognitive deficits, patients with dementia have a higher risk of contracting COVID-19 because it is harder for them to follow safety instructions intended to stop viral propagation. Additionally, older populations with dementia are more likely to suffer from more severe health impacts than younger populations without dementia. New product releases, which are expected to be the main factor driving market expansion, are predicted to suffer from the COVID-19 pandemic.

New Development

The leading European life sciences investor LSP and renowned dementia researcher Professor Philip Scheltens will launch the LSP Dementia Fund in Amsterdam in January 2022. The fund is devoted to fighting neurodegenerative diseases.

In October 2022, Alzheimer's Disease International will introduce the third Dementia Innovation Readiness Index in 30 international cities in collaboration with the Worldwide Coalition on Aging (GCOA) and the Lien Foundation.

UNIVERSITIES AND SOCIETIES:

Top Neurology Universities Worldwide:

USA Neurology Universities:

• Capella University, USA
• Columbia University, USA  
• Harvard University, USA
• University of Pittsburgh, USA
• Baylor University, USA
• Boston University, USA
• Emory University, USA
• Johns Hopkins School of Medicine, USA
• University of North Carolina Chapel Hill, USA
• New York University, USA
• University of California Los Angeles, USA
• University of California San Diego, USA
• University of California San Francisco, USA
• University of Chicago, USA
• University of Pennsylvania, USA
• University of Southern California, USA
• Vanderbilt University, USA
• Washington University, USA
• Yale University, USA
• Duke University, USA

Europe Neurology Universities:

• Heidelberg University, Germany
• University in Pavia, Italy
• Public university in Barcelona, Spain
• University in Aachen, Germany
• Sapienza University of Rome, Italy
• Lubeck University, Germany
• Maastricht University, Netherlands
• Herdecke University, Germany
• VU University Amsterdam, Netherlands
• Magdeburg University, Germany
• Munster University, Germany
• Rovira i Virgili University, Spain
• Radboud University, Netherlands
• University of Gottingen, Germany
• Wurzburg University, Germany
• Tubingen University, Germany
• University in Skovde, Sweden
• University in Helsinki, Finland
• Freiburg University, Germany
• Aalto University, Finland

Asia Neurology Universities:

• National University of Singapore, Singapore
• Shanghai Jiao Tong University, China
• Kyoto University, Japan
• University of Hong Kong, China
• University of Delhi, India
• Peking University, China
• The Hong Kong University of Science and Technology, China
• Seoul National University, South Korea
• The Chinese University of Hong Kong, China
• National Taiwan University, Taiwan
• Tsinghua University, China
• Osaka University, Japan
• Fudan University, China
• Mahidol University, Taiwan
• Korea Advanced Institute of Science and Technology, South Korea
• Yonsei University, South Korea
• Nanyang Technological University, Singapore

Top Neurology Societies Worldwide:

USA Neurology Societies:

• Massachusetts Neurologic Association, USA
• Alzheimer Association, USA
• American Association of Neuro North, USA
• American Neuromodulation Society, USA
• American Association of Neurological Surgeons, USA
• American Association of Neuromuscular & Electrodiagnostic Medicine, USA
• American Board of Psychiatry and Neurology, USA
• American Epilepsy Society, USA
• American Headache Society, USA
• American Osteopathic Board of Neurology and Psychiatry, USA
• American Society of Neurorehabilitation, USA
• Epilepsy Association-Central, USA
• National Institute of Neurological Disorders and Stroke
• Neuropsychiatric Association, USA
• North American Neuro-Ophthalmology Society, USA
• Society for Behavioral and Cognitive Neurology, USA
• Society for Neuroscience, USA
• The American Society of Neuroimaging, USA
• American Academy of Neurology, USA

Europe Neurology Societies:

• Alzheimer Society of Finland, Finland
• Czech Alzheimer Society, Czech Republic
• Dutch Society of Neurology, Netherland
• Italian Society for Neuroscience, Italy
• Alzheimer Society of Ireland, Ireland
• European Federation of Neurological Societies, Turkey
• European Academy of Neurology, Austria
• Cyprus Neurological Society, Cyprus
• Czech Neurological Society, Czech Republic
• French Society of Neurology, France
• German Society of Neurology, Germany
• Italian Society of Neurology, Italy
• Portuguese Society of Neurology, Portugal
• World Federation of Neurology, United Kingdom

Asia Neurology Societies:

• Alzheimer's Disease Association, Singapore
• Indian Academy of Neurology, India
• The Japanese Society of Psychiatry and Neurology, Japan
• Neurological Society of India, India
• Indonesian Neurology Association, Indonesia
• Asian Society Against Dementia, Singapore
• Chinese Stroke Association, China
• Asian Australasian Society of Neurological Surgeons, Australia
• Japanese Society of Neurology, Japan
• Chinese Society for Neuroscience, China
• Chinese medical association, China
• Taiwan Movement Disorder Society, Taiwan
• Taiwan Neurological Society, Taiwan

Funding Bodies in Global Health:

• Chinese Academy of Sciences
• National Natural Sciences Foundation of China
• Council for Scientific and Industrial Research
• Japan Science and Technology Agency
• The Volkswagon Stifung Foundation
• Austrian Science Fund
• Vienna Science and Technology Fund
• National Fund for Scientific Research
• Hungary Scientific Research Fund
• Canadian Foundation for Innovation
• The Brain and Behavior Research Fund
• Neuroscience Research Grants
• Health Research Council of New Zealand
• Neurological Foundation New Zealand
• South African Medical Research Council